The American Journal of Managed Care

06/12/2025

We are on-site in Milan, Italy, for !

Keep up with our coverage here: https://hubs.li/Q03rQM1W0

06/12/2025

Patients with relapsed/refractory follicular reported consistent or increased response rates, survival benefits, and health-related quality of life when taking in various different forms, according to 3 posters presented at .

Learn more here: https://hubs.li/Q03rQFTF0

06/12/2025

We are on-site in Milan, Italy, for !

Keep up with our coverage using the link in our bio.

06/12/2025

In an interview with , Dr Ola Landgren, lead investigator of the clinical trial, outlines the study’s goal of advancing modern, minimal residual disease–guided treatment approaches.

He is set to present the findings this sunday at .

Watch here: https://hubs.li/Q03rQx2S0

06/11/2025

A new blood test could make early Alzheimer’s detection more accessible and affordable.
This advancement comes during Alzheimer’s & Brain Awareness Month—spotlighting the power of early diagnosis.
Read the latest AJMC article: https://hubs.li/Q03rwdzK0

06/11/2025

TIGIT-targeted therapies have shown potential in immuno-oncology, but inconsistent clinical outcomes continue to raise questions. Experts now point to one critical factor: the absence of a reliable biomarker.

A new article from The American Journal of Managed Care® explores the current challenges and emerging strategies to unlock TIGIT’s clinical value.

Read the full article: https://hubs.li/Q03qTHZk0

06/10/2025

Introducing the new face of Evidence-Based Oncology (EBO)! Bold. Visual. Sharp.

Our new cover showcases eye-opening imagery that highlights the featured content within.

EBO is committed to advancing through rigorous analysis, expert commentary, and real-world evidence—the same trusted insights with a fresh new look.

Let us know what you think!

06/10/2025

Ahead of in Milan, Dr Ola Landgren of Sylvester Comprehensive Cancer Center shares what he is most looking forward to and reflects on key advancements and ongoing challenges in amid the meeting's 30th anniversary.

Watch here: https://hubs.li/Q03rr2Y40

06/10/2025

Untreated spinal muscular atrophy (SMA) can lead to progressive muscle weakness, respiratory complications, nutritional challenges, and a shortened lifespan.

In a recent , expert panelists explore how disease progression varies based on SMA type and SMN2 copy number, and why timely, tailored management is critical. Watch the full discussion to learn more:

Untreated Spinal Muscular Atrophy leads to severe complications and declines in quality of life, emphasizing the need for early intervention.

06/10/2025

Dr Sheela Rao, lead investigator of the POD1UM-303/InterAACT 2 trial, spoke with about the impact of the U.S. Food and Drug Administration approval of as the first first-line treatment for advanced , the importance of equitable access, and key directions for future research.

Watch here: https://hubs.li/Q03rnTYP0

06/10/2025

Convening from June 12 to June 15, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in and .

Learn more here: https://hubs.li/Q03rnRGZ0

06/10/2025

Secretary Robert F. Kennedy Jr has disbanded the Advisory Committee on Immunization Practices, aiming to restore trust in amid concerns over politicization and integrity.

Learn more here: https://hubs.li/Q03rnD9w0